Research programme: dopamine/serotonin interaction stabilisers - Adamed
Latest Information Update: 08 Jan 2014
At a glance
- Originator Adamed
- Mechanism of Action Dopamine modulators; Serotonin modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Schizophrenia
Most Recent Events
- 08 Jan 2014 Early research in Schizophrenia in Poland (unspecified route)
- 08 Jan 2014 Research programme: dopamine/serotonin interaction stabilisers - Adamed is available for licensing as of 08 Jan 2014. http://www.adamed.com.pl